Cornerstone Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$582K Hold
485
0.05% 83
2026
Q1
$446K Hold
485
0.04% 86
2025
Q4
$521K Buy
+485
New +$464K 0.05% 76
2025
Q2
Sell
-245
Closed -$202K 100
2025
Q1
$202K Buy
+245
New +$204K 0.02% 96

Other funds holding LLY

Cornerstone Capital's LLY Position: Q2 2026 in Review

Cornerstone Capital held its Eli Lilly (LLY) position steady in Q2 2026 at 485 shares worth $582K. The position accounts for 0.05% of the portfolio, ranked #83.

Cornerstone Capital first reported a position in LLY in Q1 2025 and has held it in 4 quarters since. 4,631 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cornerstone Capital held 485 shares of Eli Lilly worth $582K as of Q2 2026.
  • Cornerstone Capital left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.05% of Cornerstone Capital's portfolio in Q2 2026, its #83 holding.
  • Cornerstone Capital first reported a position in Eli Lilly in Q1 2025 and has held it in 4 quarters since.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cornerstone Capital's 13F filing for Q2 2026, filed 3 Aug 2026.